Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Selective inhibitors of JAK1 targeting an isoform-restricted allosteric cysteine
Madeline E. Kavanagh, Benjamin D. Horning, Roli Khattri, et al.
Nature Chemical Biology (2022) Vol. 18, Iss. 12, pp. 1388-1398
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

The JAK-STAT pathway at 30: Much learned, much more to do
Rachael L. Philips, Yuxin Wang, HyeonJoo Cheon, et al.
Cell (2022) Vol. 185, Iss. 21, pp. 3857-3876
Open Access | Times Cited: 393
Proteomic discovery of chemical probes that perturb protein complexes in human cells
Michael R. Lazear, Jarrett R. Remsberg, Martin G. Jaeger, et al.
Molecular Cell (2023) Vol. 83, Iss. 10, pp. 1725-1742.e12
Open Access | Times Cited: 67
JAK-STAT signaling in inflammation and stress-related diseases: implications for therapeutic interventions
Alexey Sarapultsev, Evgeni Gusev, Maria Komelkova, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 64
Expanding Chemical Probe Space: Quality Criteria for Covalent and Degrader Probes
Ingo V. Hartung, Joachim Rudolph, Mary M. Mader, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 14, pp. 9297-9312
Open Access | Times Cited: 58
Protein kinases: drug targets for immunological disorders
Leslie Castelo‐Soccio, Hanna Kim, Massimo Gadina, et al.
Nature reviews. Immunology (2023) Vol. 23, Iss. 12, pp. 787-806
Open Access | Times Cited: 57
Emerging and Re-emerging Warheads for Targeted Covalent Inhibitors: An Update
Laura Hillebrand, Xiaojun Julia Liang, Ricardo A. M. Serafim, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 10, pp. 7668-7758
Closed Access | Times Cited: 53
The JAK-STAT pathway: from structural biology to cytokine engineering
You Lv, Jianxun Qi, Jeffrey J. Babon, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 19
JAK inhibitor selectivity: new opportunities, better drugs?
Anniina Virtanen, Francesca Romana Spinelli, Jean Baptiste Telliez, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 10, pp. 649-665
Closed Access | Times Cited: 18
Assigning functionality to cysteines by base editing of cancer dependency genes
Haoxin Li, Tiantai Ma, Jarrett R. Remsberg, et al.
Nature Chemical Biology (2023) Vol. 19, Iss. 11, pp. 1320-1330
Open Access | Times Cited: 41
Allosteric TYK2 inhibition: redefining autoimmune disease therapy beyond JAK1-3 inhibitors
Lise T. Jensen, Kathrine E. Attfield, Marc Feldmann, et al.
EBioMedicine (2023) Vol. 97, pp. 104840-104840
Open Access | Times Cited: 32
Structural basis of Janus kinase trans-activation
Nathanael A. Caveney, Robert A. Saxton, Deepa Waghray, et al.
Cell Reports (2023) Vol. 42, Iss. 3, pp. 112201-112201
Open Access | Times Cited: 29
Chemical Proteomic Discovery of Isotype‐Selective Covalent Inhibitors of the RNA Methyltransferase NSUN2
Yongfeng Tao, Jan G. Felber, Zhongyu Zou, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 51
Open Access | Times Cited: 27
Inflammation versus regulation: how interferon-gamma contributes to type 1 diabetes pathogenesis
David J. De George, Tingting Ge, Balasubramaniam Krishnamurthy, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 25
Proteomic Ligandability Maps of Spirocycle Acrylamide Stereoprobes Identify Covalent ERCC3 Degraders
Zhonglin Liu, Jarrett R. Remsberg, Haoxin Li, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 15, pp. 10393-10406
Closed Access | Times Cited: 16
Small molecule drug discovery targeting the JAK-STAT pathway
You Lv, Pengbing Mi, Jeffrey J. Babon, et al.
Pharmacological Research (2024) Vol. 204, pp. 107217-107217
Open Access | Times Cited: 13
Multi-tiered chemical proteomic maps of tryptoline acrylamide–protein interactions in cancer cells
Evert Njomen, Rachel E. Hayward, Kristen E. DeMeester, et al.
Nature Chemistry (2024) Vol. 16, Iss. 10, pp. 1592-1604
Closed Access | Times Cited: 13
Activity‐Based Protein Profiling – Finding General Solutions to Specific Problems
Benjamin F. Cravatt
Israel Journal of Chemistry (2023) Vol. 63, Iss. 3-4
Open Access | Times Cited: 20
Proteome‐Wide Fragment‐Based Ligand and Target Discovery
Ines Forrest, Christopher G. Parker
Israel Journal of Chemistry (2023) Vol. 63, Iss. 3-4
Open Access | Times Cited: 18
Proteome-wide structural analysis identifies warhead- and coverage-specific biases in cysteine-focused chemoproteomics
Matthew White, Jesús Gil, Edward W. Tate
Cell chemical biology (2023) Vol. 30, Iss. 7, pp. 828-838.e4
Open Access | Times Cited: 17
Covalent hits and where to find them
Simon C. C. Lucas, J. Henry Blackwell, Sarah H. Hewitt, et al.
SLAS DISCOVERY (2024) Vol. 29, Iss. 3, pp. 100142-100142
Open Access | Times Cited: 7
Delineating cysteine-reactive compound modulation of cellular proteostasis processes
Ashley R. Julio, Flowreen Shikwana, Cindy Truong, et al.
Nature Chemical Biology (2024)
Closed Access | Times Cited: 7
Ligand discovery by activity-based protein profiling
Micah J. Niphakis, Benjamin F. Cravatt
Cell chemical biology (2024) Vol. 31, Iss. 9, pp. 1636-1651
Closed Access | Times Cited: 6
Expanding the ligandable proteome by paralog hopping with covalent probes
Yuanjin Zhang, Zhonglin Liu, Marsha Hirschi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
Covalent fragment-based drug discovery for target tractability
William J. McCarthy, Antonie J. van der Zouwen, Jacob T. Bush, et al.
Current Opinion in Structural Biology (2024) Vol. 86, pp. 102809-102809
Open Access | Times Cited: 5
Chemical Proteomics–Guided Discovery of Covalent Ligands for Cancer Proteins
Xiaoyu Zhang, Benjamin F. Cravatt
Annual Review of Cancer Biology (2024) Vol. 8, Iss. 1, pp. 155-175
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top